pyrazolanthrone has been researched along with Leukemia, Myelomonocytic, Juvenile in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, EM; Chan, RJ; Flotho, C; Hashino, E; Kondo, T; Kratz, CP; Nabinger, SC; Ndong, L; Niemeyer, CM; Voorhorst, CS; Würstlin, O; Yang, Z; Yin, F; Yu, M | 1 |
1 other study(ies) available for pyrazolanthrone and Leukemia, Myelomonocytic, Juvenile
Article | Year |
---|---|
Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.
Topics: Animals; Anthracenes; Cell Differentiation; Child; Enzyme Activation; GATA2 Transcription Factor; Gene Expression Regulation; Hematopoietic Stem Cells; Humans; Infant; JNK Mitogen-Activated Protein Kinases; Leukemia, Myelomonocytic, Juvenile; Mast Cells; Mice; Monocytes; Mutation; NIH 3T3 Cells; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; ras Proteins; Receptor, Macrophage Colony-Stimulating Factor | 2009 |